Esri Launches Content Store for ArcGIS to Provide Easier Access to On-Demand, GIS-Ready Imagery
Esri, the global market leader in location intelligence, is launching Content Store for ArcGIS, a new web app that simplifies the process of purchasing and integrating commercial satellite imagery. This app, developed by Esri and SkyWatch, allows organizations to buy high-quality imagery from Esri’s cornerstone partner, Maxar, as well as other leading providers. Previously, users had to manage multiple providers and manually import data, but Content Store for ArcGIS streamlines this workflow, making it easier and more efficient.
“Content Store for ArcGIS offers a seamless, on-demand experience for accessing premium commercial imagery, right within the ArcGIS platform,” said Richard Cooke, Esri Corporate Director of Global Business Development. “This new experience addresses the challenges our users have shared with us as their use of commercial imagery expands into more and more of their business or mission critical workflows. We believe this will also add significant value to the open imagery sources already available through ArcGIS Living Atlas.”
“SkyWatch is thrilled to partner with Esri to bring Content Store for ArcGIS to life,” said James Slifierz, Co-Founder and CEO of SkyWatch. “Our mission is to make premium geospatial data easily accessible in the broadest range of applications, and this integration with ArcGIS illustrates the power of the SkyWatch Platform. We are excited to support Esri users in enhancing their spatial analyses with high resolution imagery, and other forms of geospatial data to follow.”
In addition to the launch partners, Esri and SkyWatch will be working together to continually add other providers to Content Store for ArcGIS, to give users even greater flexibility to find and acquire the content that best meets the needs of their work.
“We are proud to continue our decades-long partnership with Esri by augmenting the Maxar imagery basemaps already available through ArcGIS Living Atlas of the World,” said Paul Granito, Maxar’s General Manager and Senior Vice President of Enterprise. “We partnered with Esri and SkyWatch to provide Content Store for ArcGIS with access to our most current, very high-resolution imagery to support users who need frictionless access to that data within ArcGIS. We look forward to empowering the geospatial community with our data to enable critical workflows and better organizational decision making.”
Imagery from open datasets such as Landsat or Sentinel is a valuable asset to organizations that use geospatial data in their workflows. But increasingly, users in fields like land management, urban planning, sustainable development, asset risk management, and infrastructure planning need more diverse, up-to-date, higher resolution satellite imagery than ever before. Content Store for ArcGIS eliminates the friction involved in acquiring and integrating this commercial imagery. Instead of navigating multiple provider portals and contracting with each one separately, enterprise data procurement managers can log in and purchase imagery directly within ArcGIS using their existing credentials. This integration not only streamlines the process of acquiring commercial imagery but also complements the extensive data available from ArcGIS Living Atlas and other public repositories, enhancing the overall value and functionality for ArcGIS users.
To learn more about Content Store for ArcGIS, visit esri.com/arcgis-blog/products/arcgis-online/imagery/access-commercial-imagery-in-arcgis/.
About Esri
Esri, the global market leader in geographic information system (GIS) software, location intelligence, and mapping, helps customers unlock the full potential of data to improve operational and business results. Founded in 1969 in Redlands, California, USA, Esri software is deployed in hundreds of thousands of organizations globally, including Fortune 500 companies, government agencies, nonprofit institutions, and universities. Esri has regional offices, international distributors, and partners providing local support in over 100 countries on six continents. With its pioneering commitment to geospatial technology and analytics, Esri engineers the most innovative solutions that leverage a geographic approach to solving some of the world’s most complex problems by placing them in the crucial context of location. Visit us at esri.com.
Copyright © 2025 Esri. All rights reserved. Esri, the Esri globe logo, ArcGIS, The Science of Where, esri.com, and @esri.com are trademarks, service marks, or registered marks of Esri in the United States, the European Community, or certain other jurisdictions. Other companies and products or services mentioned herein may be trademarks, service marks, or registered marks of their respective mark owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250224547682/en/
Contacts
Jo Ann Pruchniewski
Public Relations, Esri
Mobile: 301-693-2643 Email: jpruchniewski@esri.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release
Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release
IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release
HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom